Cha Bundang Medical Center, Cha University

Gyeonggido, Gyeonggi-do 13496

0 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma (HNSCC), Limited Stage Small Cell Lung Cancer, NSCLC, Nasopharyngeal Carcinoma (NPC), Non Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors — Completed
• Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer — Completed